The TRUTH in Coverage Act of 2026 requires group health plans and health insurance issuers that cover gender-affirming procedures to also cover medical services intended to treat physical and psychological complications resulting from those procedures. This mandate applies regardless of whether the original gender-affirming treatment was covered by the plan and ensures that any required follow-up care faces the same cost-sharing rules and limitations as standard medical benefits. The bill defines "sex-rejecting procedures" broadly to include hormone therapy, surgeries, and puberty blockers, while explicitly excluding treatments for intersex conditions, life-threatening emergencies, and standard puberty suppression for early puberty. These provisions would take effect for plan years beginning on or after January 1, 2027, affecting individuals with access to employer-sponsored or individual health insurance.
This concurrent resolution does not create new laws or change existing regulations but serves to formally recognize the ongoing need for better physical access in federally funded facilities, especially for people with disabilities. It highlights statistics on disability prevalence and employment gaps while reaffirming support for the Architectural Barriers Act of 1968 and the Americans with Disabilities Act of 1990. The measure pledges to use universal and inclusive design as a guiding principle for future infrastructure projects and encourages full compliance with current accessibility laws.
The ONSHORE Manufacturing Act creates three new tax credits to financially encourage the domestic production of essential medical supplies and equipment. The first credit provides a percentage of a company's taxable income based on wages paid to workers manufacturing specific drugs, devices, and ingredients listed as critical for national security or defense. The second and third credits offer tax breaks for businesses that purchase and install advanced machinery or environmental compliance equipment used to produce these same medical products within the United States. These incentives are designed to support companies that manufacture specified medical goods in whole or significant part domestically, with the benefits applying to taxable years beginning after December 31, 2026. Additionally, the bill requires several federal agencies to submit annual reports to Congress starting in 2027 to track how these credits affect supply chain resiliency and adherence to domestic procurement laws.
The SECURED Act of 2026 requires digital platforms that list short-term rentals to ask property owners if they are registered child sex offenders and to publicly display that status if the owner answers yes. Property owners who are registered offenders must respond truthfully to these requests, while platforms must provide a direct link to a public registry so guests can verify the information before booking. The Federal Trade Commission is authorized to enforce these rules as unfair business practices, and state attorneys general can also sue to stop violations or seek damages on behalf of residents. The law will not take effect until one year after it is signed into law.
This bill, known as the Daughters of the American Revolution Membership Integrity Act, amends federal law to explicitly limit membership in the Daughters of the American Revolution to adult human females. It defines a female as someone who naturally possesses or would have the reproductive system capable of producing ova for fertilization, regardless of any congenital anomalies or medical disruptions. By adding this specific definition to the organization's governing code, the legislation clarifies the genealogical and biological requirements for joining the group. The change directly affects the organization's eligibility rules but does not alter its internal operations or funding.
This bill, known as the Cyber Letters of Marque and Reprisal Act, authorizes the President to issue official commissions to private individuals or companies, allowing them to conduct specific cyber operations against foreign entities identified as cyberthreats. Under these commissions, private actors could perform tasks such as collecting intelligence, seizing stolen digital assets, and disrupting malicious infrastructure outside U.S. borders, provided they do not target American citizens or organizations. To participate, recipients must post a security bond, maintain detailed activity logs for at least five years, and may be required to forfeit a portion of recovered funds to support a bounty program for future operations. The legislation also grants holders immunity from lawsuits for actions explicitly authorized by their commission and establishes a framework for awarding bounties to both commissioned agents and private informants who assist in recovering funds from cybercriminals.
The Patients First Act of 2026 modifies how Medicare reimburses physicians and primary care providers to improve access and stabilize payments. It establishes a new hybrid payment model for primary care services from 2027 to 2031, which pays a monthly fee per patient to eligible independent practices while covering specific services like care management and telehealth without cost-sharing for patients. The bill also updates the formula for calculating reimbursement rates to account for high inflation years and requires more frequent updates to the costs used in calculating payments. Additionally, the legislation reforms the performance-based payment system by adding care efficiency measures, creating a task force to recommend new quality metrics, and adjusting penalties for providers who fail to report on certain data.
HR 7651, the Chloe Cole Act of 2026, prohibits healthcare providers from performing certain medical interventions on minors under 18 aimed at altering physical development to align with gender identity. These "covered interventions" include puberty blockers, hormone treatments, and specific surgeries, but exclude medically necessary care for conditions like disorders of sexual development or traumatic injuries. The bill creates a federal civil lawsuit right for affected minors or their parents against providers who perform such interventions, allowing claims for damages including emotional distress and punitive awards, with strict liability for providers after the law's enactment. It explicitly allows exceptions for legitimate medical treatments and requires providers to prove such exceptions apply if challenged.
HR 7184, the PRESS Act, targets equipment used to manufacture illegal drugs by making it unlawful to sell specific items like tableting machines, gelatin capsules, or related chemicals when the seller knows the equipment will be used to produce controlled substances for unlawful U.S. importation. It directly affects manufacturers and distributors of these drug-making tools who have knowledge or reasonable cause to believe their products will facilitate illegal drug trafficking. The bill adds new prohibitions to the Controlled Substances Act and increases potential prison sentences for violations, with penalties reaching up to 20 years for major offenses involving large quantities of equipment or chemicals. These changes aim to disrupt the supply chain for illicit synthetic drugs by holding equipment sellers accountable for their intended use.
This bill requires Medicare Advantage plans to implement electronic pre-approval systems for medical services by 2028 and meet transparency reporting standards starting in 2027. Plans must publicly report data on approval/denial rates, appeal outcomes, response times, and technology use for pre-approval requests, including details on how denials relate to clinical criteria. It establishes a 24-hour response timeframe for certain requests and mandates annual reviews of pre-approval requirements based on data and input from seniors and providers. The law directly affects Medicare Advantage plans, seniors enrolled in these plans, and healthcare providers who submit pre-approval requests. These changes aim to make the pre-approval process faster, more transparent, and more accountable for seniors seeking covered medical services.
HR 3108, the RPM Access Act, increases Medicare reimbursement for remote patient monitoring (RPM) in rural areas by setting a minimum reimbursement floor of 100% for practice expenses and malpractice costs starting in 2026. It requires that RPM services include real-time physician availability to address health issues, use data systems compatible with electronic health records, and mandates providers to report data on cost savings and adherence to medications. The bill directly affects rural Medicare beneficiaries with chronic conditions like heart failure and diabetes, as well as healthcare providers delivering RPM services in underserved rural communities. It also requires a 5-year report to Congress analyzing cost savings from RPM use, including reduced hospitalizations and medication adherence. The law aims to improve access to RPM in rural areas where healthcare shortages are most severe.
Protecting Privacy in Purchases Act This bill prohibits payment card networks from using merchant codes that distinguish firearms retailers from general-merchandise retailers or sporting-goods retailers. The Department of Justice must enforce this bill and report annually on the resulting investigations and cases.
